bpc-157 human clinical evidence safety fda warning trials review trial Peptides are having a moment. Influencers An FDA Reversal on Peptides bpc-157 fda warning not approved

What Is NAD

Fascinating cellular biology can generate legitimate scientific curiosity, seen in epitalon lifespan narratives that weave mechanistic findings into broad promises

What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have

B12 injections have different strengths, and knowing this helps us give the right dose